Elicio Therapeutics Inc
(ELTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 8,045 | 10,091 | 10,736 | 13,477 | 10,344 |
| Operating Income | -8,045 | -10,091 | -10,736 | -13,477 | -10,344 |
| Interest Expense | 426 | 194 | 176 | 233 | 137 |
| Other Income | -1,612 | -276 | -297 | -294 | -8,357 |
| Pre-tax Income | -10,083 | -10,561 | -11,209 | -14,004 | -18,838 |
| Net Income Continuous | -10,083 | -10,561 | -11,209 | -14,004 | -18,838 |
| Net Income | $-10,083 | $-10,561 | $-11,209 | $-14,004 | $-18,838 |
| EPS Basic Total Ops | -0.60 | -0.66 | -0.87 | -1.07 | -1.39 |
| EPS Basic Continuous Ops | -0.60 | -0.66 | -0.87 | -1.07 | -1.39 |
| EPS Diluted Total Ops | -0.60 | -0.66 | -0.87 | -1.07 | -1.39 |
| EPS Diluted Continuous Ops | -0.60 | -0.66 | -0.87 | -1.07 | -1.39 |
| EPS Diluted Before Non-Recurring Items | -0.60 | -0.66 | -0.87 | -1.02 | -1.39 |
| EBITDA(a) | $-7,762 | $-9,810 | $-10,423 | $-13,123 | $-10,028 |